Iq Eq Fund Management (Ireland) LTD 10x Genomics, Inc. Transaction History
Iq Eq Fund Management (Ireland) LTD
- $934 Million
- Q3 2024
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 20,232 shares of TXG stock, worth $313,191. This represents 0.05% of its overall portfolio holdings.
Number of Shares
20,232
Previous 11,081
82.58%
Holding current value
$313,191
Previous $215,000
112.09%
% of portfolio
0.05%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
291Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$170 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$166 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$100 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$99 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$98.7 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.47B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...